Yeoh et al71 also reported a significant loss of GALNT7 mRNA in conjunction with a reduced leukemia burden in B-cell precursor patient samples during the course of initial induction chemotherapy (also see Supplementary Fig. 6). Here, GALNT7 is linked to leukemia.